CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BMO Capital Initiates LB Pharmaceuticals at Outperform With $46 Price Target

Positive
AI Analysis

Summary

BMO Capital initiated coverage of LB Pharmaceuticals with an Outperform rating and a $46 price target.

Importance:2/10
Sentiment:
0.60
analyst_initiationprice_targetoutperform
Related Companies

Read the original article

Published by yahoo_finance on July 21, 2026 11:37 AM

Read Original